Equities research analysts at Wedbush upped their Q1 2025 earnings per share estimates for Beam Therapeutics in a research note issued on Monday, March 10th. Wedbush analyst D. Nierengarten now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback